1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Family Centered Treatment-Recovery® in the Specialized Women’s Services Program is sponsored by Arkansas DHS and OSAMH (funded through a State Opioid Response (SOR) grant). This initiative integrates the Family Centered Treatment-Recovery (FCT-R) model into Arkansas's Specialized Women's Services (SWS) program, providing residential treatment for pregnant and parenting mothers with substance use disorders.
Get alerted about grants like this
Get emailed when new opportunities from “Arkansas DHS and OSAMH (funded through a State Opioid Response (SOR) grant)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Providers participating in the Arkansas Specialized Women's Services (SWS) program. Funding supports training, supervision, and fidelity to the FCT model. Confirm the full requirements in the official notice before applying.
Family Centered Treatment-Recovery® in the Specialized Women’s Services Program is funded by Arkansas DHS and OSAMH (funded through a State Opioid Response (SOR) grant). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Arkansas. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The RCORP-Planning and RCORP-Impact programs offer $100K to $750K/year for rural communities fighting substance use disorder. Applications close May 29 and June 1. A strategic guide for first-time and returning applicants.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read article